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Tumor necrosis factor (TNF) constitutes a critical
host defense against tuberculosis, but its excess is
also implicated in tuberculosis pathogenesis in
zebrafish and humans. Using the zebrafish, we
elucidate the pathways by which TNF mediates
tuberculosis pathogenesis. TNF excess induces
mitochondrial reactive oxygen species (ROS) in in-
fected macrophages through RIP1-RIP3-dependent
pathways. While initially increasing macrophage
microbicidal activity, ROS rapidly induce pro-
grammed necrosis (necroptosis) and release myco-
bacteria into the growth-permissive extracellular
milieu. TNF-induced necroptosis occurs through
two pathways: modulation of mitochondrial cyclo-
philin D, implicated in mitochondrial permeability
transition pore formation, and acid sphingomyeli-
nase-mediated ceramide production. Combined
genetic blockade of cyclophilin D and acid sphingo-
myelinase renders the high TNF state hyperresistant
by preventingmacrophage necrosis while preserving
increased microbicidal activity. Similarly, the cyclo-
philin D-inhibiting drug alisporivir and the acid
sphingomyelinase-inactivating drug, desipramine,
synergize to reverse susceptibility, suggesting the
therapeutic potential of these orally active drugs
against tuberculosis and possibly other TNF-medi-
ated diseases.INTRODUCTION
Although tuberculosis (TB) has traditionally been linked to failed
immunity, recent work has implicated excessive inflammation in
increased tuberculosis susceptibility (Agarwal et al., 2009; Berg
and Ramakrishnan, 2012; Tobin et al., 2012). Studies in the ze-
brafish revealed that leukotriene A4 hydrolase (LTA4H) mediates
susceptibility to Mycobacterium marinum (Mm) infection (Tobinet al., 2012; Tobin et al., 2010). LTA4H catalyzes the final step
in the formation of the inflammatory lipid mediator leukotriene
B4 (LTB4), and LTA4H deficiency shunts eicosanoid production
from LTB4 to anti-inflammatory lipoxins that inhibit tumor necro-
sis factor (TNF) production. LTA4H excess increases LTB4,
which induces TNF. Despite their opposite effects on TNF levels,
LTA4H deficiency (LTA4H-low) and excess (LTA4H-high) states
both produce susceptibility via necrosis of infected macro-
phages, allowing the release of mycobacteria into the growth-
permissive extracellular milieu (Tobin et al., 2012). The TNF
deficit in the LTA4H-low state reduces macrophage microbicidal
activity, leading to increased intracellular bacterial growth fol-
lowed by necrosis of the overladen macrophages (Tobin et al.,
2010) (Figure 1). The high LTA4H/TNF state produces necrosis
of infected macrophages despite their enhanced capacity to
curtail bacterial growth (Figure 1).
In humans, a common single nucleotide polymorphism that
regulates LTA4H expression was associated with TB meningitis
severity (Tobin et al., 2012). Individuals homozygous for the high
expression and low expression alleles had similarly increased
disease severity. Heterozygotes with an intermediate inflamma-
tory state were the least susceptible. Of therapeutic importance,
individuals with the low and high inflammatory states had diver-
gent responses to adjunctive glucocorticoid treatment routinely
given for TB meningitis. The survival benefit conferred by these
potent anti-inflammatory drugs was confined to persons with
the proinflammatory LTA4H genotype—with data suggesting
that glucocorticoids might increase mortality in persons with
the low inflammatory LTA4H genotype.
Having established the importance of the high LTA4H/TNF
state in human TB severity and treatment responsiveness, it
was important to understand the mechanisms by which TNF
excess produces susceptibility. Using the zebrafish, we interro-
gated themolecular pathways whereby high TNF promotes early
macrophage resistance to mycobacteria only to be followed by
macrophage lysis and extracellular bacterial proliferation. We
show that excess TNF activates a programmed necrosis (nec-
roptosis) pathway through mitochondrial ROS production. We
have identified pharmacologic interventions in this pathway
including alisporivir, a cyclophilin D inhibitor in phase III
clinical trials for treatment of hepatitis C, and desipramine, aCell 153, 521–534, April 25, 2013 ª2013 Elsevier Inc. 521
Figure 1. Zebrafish Susceptibility Pheno-
types and Assays in LTA4H/TNF-Low
and -High Stateslong-used tricyclic antidepressant that inactivates acid sphingo-
myelinase. Along with the identification of highly specific, geno-
type-directed therapies for TB, our findings may provide insights
into the pathogenesis of, and therapeutic possibilities for, other
inflammatory diseases that respond to TNF blockade.
RESULTS
TNF Excess Triggers ROS Production that Kills Both
Mycobacteria and Infected Macrophages
We searched for a common mechanism by which excess TNF
produced in the LTA4H-high state might kill intracellular bacteria
and then the infected macrophages themselves. We considered
previous findings that TNF-induced necrosis can occur through
induction of ROS, which are powerful microbicidal agents
(Schulze-Osthoff et al., 1992; Vandenabeele et al., 2010). Incu-
bation of infected LTA4H-high fish, created by the injection of
lta4hRNA (Tobin et al., 2012), with four different ROS scavengers
(NAC, GSH, amifostine, and TEMPOL) abolished both the initial
macrophage microbicidal activity and the subsequent increase
in whole fish bacterial burdens that result upon macrophage522 Cell 153, 521–534, April 25, 2013 ª2013 Elsevier Inc.death (Figures 1, 2A–2C and Figures
S1A–S1F and Table S1 available online).
ROS scavengers did not render WT fish
hypersusceptible, consistent with the
literature reporting that Mm and Myco-
bacterium tuberculosis (Mtb) have multi-
ple mechanisms to counter ROS to the
extent that it is produced in WT infection
(Figures 2A and 2B and S1A–S1F) (Chan
et al., 1992; Cirillo et al., 2009; Ehrt and
Schnappinger, 2009; Subbian et al.,
2007). Reactive nitrogen species (RNS)
have been shown to work in conjunction
with ROS to induce programmed necro-
sis under some conditions (Davis et al.,
2010). However, they were not involved
here. The nitric oxide (NO) scavenger
c-PTIO had no effect on LTA4H-high bac-
terial burdens, while increasing those of
WT animals consistent with the known
mycobactericidal role of NO in mamma-
lian systems (MacMicking et al., 1997)
(Figure S2 and Table S1).
As TNF is the principal mediator of
LTA4H-high susceptibility, ROS scav-
enging should also reverse the pheno-
types of animals rendered into a high
TNF state by recombinant TNF injection
(Tobin et al., 2012). As expected, NAC
increased intramacrophage and overall
bacterial burdens of 1 day postinfection(dpi) animals within 10 hr of coadministration with TNF (Figure 2D
and data not shown); this effect was reversed 48 hr later (Fig-
ure 2E). Thus, TNF-induced ROS mediate their bactericidal
effect within hours but this effect is soon nullified.
Our prior work showed that the secondary increase in bacterial
burdens was associated with macrophage lysis (Tobin et al.,
2012). In addition to macrophages, neutrophils can also become
infected in the early granuloma and mediate oxidative bacterial
killing (Yang et al., 2012). To determine if neutrophils were
also being lysed by the increased ROS generated in the
LTA4H-high/TNF-high state, we used a double transgenic line
Tg(mpeg1:YFP)/Tg(lyz:DsRED2) with yellow fluorescent macro-
phages and red fluorescent neutrophils. As expected, macro-
phages were reduced at 2 dpi, when the early reduction of
bacterial burdens is first nullified and extracellular bacteria are
first discernible (Figures 2F and 2G and data not shown). How-
ever, neutrophil numbers were unchanged (Figure 2F). We found
no reduction in macrophage numbers in uninfected LTA4H/TNF-
high animals both by assessing mpeg1:YFP-positive cells and
cells staining with neutral red, a macrophage-specific vital stain
(Yang et al., 2012) (Figures 2H and S3A). Thus, the high TNF state
does not lead to a baseline reduction in macrophage develop-
ment or survival; rather, macrophages are depleted only upon
infection. Finally, we confirmed that the ROS scavenger NAC
reversed the macrophage lysis and the ensuing bacterial cord-
ing, a reliable indicator of the presence of extracellular bacteria,
of TNF-high animals (Figures 2F, 2I, and 2J and S3B).
To verify independently that TNF-high susceptibility wasmedi-
ated via excess ROS, we quantified ROS production in live
animals using the cell-permeant ROS indicator CM-H2DCFDA,
which fluoresces green upon oxidation. Fluorescence micro-
scopy at 1 dpi revealed only infected TNF-high to have bright
green fluorescent (ROS-positive) cells, whereas neither infected
WT nor TNF-high uninfected animals did. The ROS-positive cells
were invariably infected, further suggesting that only infected
macrophages produce ROS (Figure 2K). Whole-animal quantita-
tion of ROS production by fluorimetry confirmed ROS to increase
only in infected TNF-high fish, suggesting that TNF excess and
infection must act in concert to increase ROS production (Fig-
ure 2L). NAC abolished this ROS production, corroborating
that it reduces susceptibility in high TNF animals specifically
through its ROS scavenging activity (Figure 2M). Finally, we
showed that the increased ROS is macrophage-dependent by
using a PU.1 morpholino to selectively knock down macro-
phages (Clay et al., 2007; He et al., 2012; Su et al., 2007). Macro-
phage depletion of TNF-high fish returned ROS levels to WT
despite having similar bacterial burdens at the time of assess-
ment (Figure 2N and data not shown).
Collectively, these experiments reveal that TNF excess in-
creases ROS production in infectedmacrophages. This increase
is initially bactericidal, but rapidly becomes host detrimental by
lysing the infected macrophages and placing mycobacteria in
a permissive extracellular milieu.
TNF Excess Mediates Necrosis through the RIP1-RIP3
Kinase Pathway
TNF can mediate apoptosis and programmed necrosis, both of
which are found in TB and have been associated with ROS
production (Fiers et al., 1999; Laster et al., 1988; Ramakrishnan,
2012). We ruled out that high TNF-mediated cell death was
occurring through apoptosis by showing that the pancaspase in-
hibitor Q-VD-OPh, which reduces TUNEL-positivemacrophages
in zebrafish larval granulomas by 90% (Yang et al., 2012) did
not rescue LTA4H/TNF-high hypersusceptibility (Figure S4 and
Table S1). TNF-mediated programmed necrosis typically in-
volves the receptor-interacting serine-threonine kinases 1 and
3 (RIP1 and RIP3), as evidenced in human, mouse, and zebrafish
cell lines, aswell as in amurine sepsismodel (Cho et al., 2009; He
et al., 2009; Holler et al., 2000; Zhang et al., 2009). Zebrafish
orthologs of human RIP1 and RIP3 are similarly organized with
strong conservation of all functional domains (Myers and Miller,
1988; Vandenabeele et al., 2010) (Figure 3A). To initiate necrosis,
the TNF-TNF receptor complex typically first recruits RIP1 via
death domain interactions. RIP3 then binds to RIP1 via their
RHIM domains. RIP1-RIP3 binding initiates RIP3 phosphoryla-
tion, which in turn activates other members of the so-called
necroptosome complex. RIP1 and RIP3 mopholino knockdown
reversed both of the phenotypes associated with the LTA4H-
high state: early macrophage microbicidal activity and thesubsequent increased bacterial burdens associated with bacte-
rial cording (Figures 3B–3G). We confirmed that they similarly
reversed TNF-high phenotypes as well (Figures 3H–3J). The
mammalian RIP1 inhibitors, necrostatin-1 and necrostatin-5
also reversed the LTA4H-high phenotypes (Figures 3K–3M and
S5A–S3C and Table S1) (Degterev et al., 2008). RIP1 and RIP3
knockdown did not alter the bacterial burden of WT and
LTA4H-low animals, showing that this programmed necrosis
pathway operates only under LTA4H/TNF-high conditions in
the context of mycobacterial infection (Figures S5D–S5H).
The TNF-RIP1-RIP3 Axis Mediates Necrosis of Infected
Macrophages through Mitochondrial ROS Production
The mitochondrion is a major source of cellular ROS, and mito-
chondrial ROS are implicated in the pathogenesis of a variety
of diseases (Nunnari and Suomalainen, 2012; Orrenius et al.,
2007). Although apoptotic cell death has long been linked to
the mitochondrion, recent literature reports the role of the mito-
chondrion in programmed necrosis with the identification of RIP3
substrates essential for this process (Sun et al., 2012; Wang
et al., 2012; Zhang et al., 2009). To determine whether the
TNF-mediated necrosis occurring in Mm infection involves the
mitochondrion, we took two experimental approaches. First,
we asked if the susceptibility phenotypes would be abrogated
by Necrox-5, a new ROS scavenger that localizes mainly to the
mitochondrion and inhibits TNF/RIP1-3-dependent necroptosis
in different mammalian systems (Kim et al., 2010a) (Table S1).
Necrox-5 reversed the late increase in bacterial burdens and
cording of both LTA4H-high and TNF-high animals without
altering bacterial burdens in WT and LTA4H-low animals, sug-
gesting a specific role for mitochondrial ROS in TNF-mediated
susceptibility (Figures 4A–4D and data not shown).
Next, we assessed the impact of the recently discovered RIP3
substrates MLKL and PGAM5, which link programmed necrosis
to the mitochondrion (Sun et al., 2012; Wang et al., 2012; Zhang
et al., 2009). RIP3 binds and phosphorylates MLKL, and this
complex then serves as a platform for the binding and activa-
tion of the mitochondrial phosphatase PGAM5. Activated
PGAM5 dephosphorylates Drp1, enabling it to form homodimers
required for mitochondrial fission and fusion (Sun et al., 2012;
Wang et al., 2012; Zhang et al., 2009). By promoting processes
closely linked to mitochondrial turnover, Drp1 has also been
shown to trigger ROS production and cell death (Suen et al.,
2008). We could not identify the zebrafish ortholog for MLKL
for morpholino knockdown. So we used the small molecule
called necrosulfonamide, which binds human MLKL and
sterically hinders its binding to RIP3 (Sun et al., 2012). Necrosul-
fonamide specifically reversed LTA4H-high hypersusceptiblity
(Figure 4E). Similarly, a PGAM5morpholino knockdown reversed
all LTA4H-high susceptibility phenotypes (Figures 4F–4H).
These experiments provided genetic evidence for mitochon-
drial involvement in LTA4H/TNF-high macrophage lysis and sus-
ceptibility. We next sought to visualize directly this sequence of
events. Infected larvae were injected with TNF or vehicle for 2 hr,
after which they were injectedwithMitoTracker Red CM-H2Xros,
a redox-sensitive dye that targets the mitochondrion and fluo-
resces red upon oxidation (Kweon et al., 2001) and SYTOX
green, a cell membrane impermeable nucleic acid stain. WithCell 153, 521–534, April 25, 2013 ª2013 Elsevier Inc. 523
Figure 2. TNF-Mediated ROS Production Kills Both Mycobacteria and Infected Macrophages
(A) Mean (±SEM) number of bacteria per infectedmacrophage inWT and LTA4H-high larvae in presence or absence of 40 mMNAC. ***p < 0.001 (one way ANOVA
with Tukey’s posttest).
(B) Bacterial burden (FPC) in WT and LTA4H-high siblings in presence or absence of 40 mM NAC. **p < 0.01 (one-way ANOVA with Tukey’s posttest).
Representative of two independent experiments.
(C) Representative fluorescence microscopy images of individual fish in (B) represented by red dots.
(D) FPC of 1 dpi larvae injectedwith TNF or vehicle in the presence or absence of 40 mMNAC. *p < 0.05 (one-way ANOVAwith Tukey’s posttest). Representative of
two independent experiments.
(E) FPC 3 dpi of the same fish in (D). *p < 0.05; **p < 0.01 (one-way ANOVA with Tukey’s posttest). Representative of two independent experiments.
(F) Number of yellow fluorescent macrophages or red fluorescent neutrophils in 2 dpi fish one day after injection with TNF or vehicle in presence or absence of
40 mM NAC. ***p < 0.001 (one-way ANOVA with Tukey’s posttest).
(legend continued on next page)
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this combination, only mitochondrial ROS production should
render cells red fluorescent, and only cells with compromised
cell membranes should become green fluorescent. We pre-
dicted that (1) red fluorescent macrophages will be found only
after TNF administration and will comprise mostly of infected
cells, and (2) red fluorescence will precede green fluorescence,
the appearance of which will be associated with a loss of cellular
integrity. Serial imaging of 40 infected animals over 7 hr after TNF
administration confirmed these predictions. Red fluorescence
first appeared 3 hr after TNF administration and was restricted
to infected macrophages (Figure 4I). No red fluorescence
was observed in vehicle-treated animals. Green fluorescence
appeared after an additional 2 hr, and only in red fluorescent cells
(Figures 4J and 4K). Its appearance was associated with the
progressive loss of membrane integrity on bright-field imaging
(Figures 4I–4K). These serial microscopical observations corrob-
orate the genetic data that TNF induces programmed necrosis of
Mycobacterium-infected macrophages through mitochondrial
ROS production.
Finally, we asked if TNF activation of phagosomal oxidase
NOX2 (gp91phox) contributed to our phenotypes because of the
following connections in the literature: (1) in phagocytes, TNF is
a potent NOX2 activator (Dewas et al., 2003), and (2) in fibro-
blasts, TNFR-RIP-1 activation of NOX1 (nonphagocytic NOX2
isoform)-derived ROS induces necrosis (Kim et al., 2007). In
this instance, NOX1 activation is required to sustain theROSpro-
duction that is initiated in the mitochondrion (Lee et al., 2006b).
However, we found that in LTA4H-high animals, morpholino
gp91phox knockdown reversed neither early resistance nor later
susceptibility (Figures S6A and S6B). Morpholino efficacy was
confirmed by showing that gp91phox morphants had the ex-
pected susceptibility to Pseudomonas aeruginosa (Figure S6C)
(Yang et al., 2012). In sum, our data suggest a direct and sole
TNF-mediated induction of mitochondrial ROS during infection.
Cyclophilin D Regulates the Mitochondrial Permeability
Transition Pore Complex to Induce TNF-Mediated
Necrosis
How do mitochondrial ROS trigger cell necrosis? Prior findings
suggested this may occur via formation of the mitochondrial
permeability transition pore complex (mPTPC), a crucial step in
mitochondrial demolition (Figure S7) (Baines et al., 2005; Cromp-
ton et al., 1988; Nakagawa et al., 2005). Themitochondrial matrix(G) Confocal microscopy of granulomas in 3 dpi Tg(mpeg1:YFP) larvae inje
Scale bar, 10 mm.
(H) Number of yellow fluorescent macrophages in Tg(mpeg1:YFP) uninfected fish
t test. Representative of two independent experiments.
(I) Representative fluorescence microscopy images of 4 dpi WT and LTA4H-high
(J) Percentage of animals in (D) and (E) with cording 4 dpi. ***p < 0.001 (Fisher’s
(K) Representative fluorescence microscopy images of 1 dpi LTA4H-high larv
macrophages. Scale bar, 10 mm.
(L) Quantification of ROS production as relative fluorescence units (RFU) (±SEM) in
at the indicated time points after injection of TNF or vehicle. (two-way ANOVA). R
(M) Quantification of ROS production as RFU (±SEM) inWT infected siblings at the
40 mM NAC. (two-way ANOVA).
(N) Quantification of ROS production as RFU (±SEM) in infected WT or PU.1 m
(two-way ANOVA).
(Also see Figures S1, S2, and S3).protein cyclophilin D (CYPD) has been shown to be a critical
regulator of mPTPC activity in response to oxidative or calcium
stress (Figure S7) (Vandenabeele et al., 2010). CYPDmorpholino
knockdown reversed the high bacterial burdens of LTA4H-high
fish, suggesting mPTPC involvement (Figure 5A). Given that
this intervention is downstream of TNF-mediated ROS produc-
tion, our model predicts that CYPD knockdown should preserve
the early increased macrophage microbicidal activity that is
reversed by interventions upstream of ROS production. We
found this to be the case (Figure 5B—compare to Figures 3B,
3E, 3H and 3K, and 4F where macrophage microbicidal activity
was measured in the context of RIP1, RIP3, and PGAM5). ROS
quantification in the corresponding morphants further confirms
the model—RIP1, RIP3, and PGAM5 knockdown reduced ROS
of TNF-high fish down to WT levels. In contrast, ROS levels
were higher in TNF-high CYPD morphants, likely due to con-
tinued production by intact infected macrophages (Figure 5C).
Collectively these data implicate CYPD and the mPTPC in the
pathogenesis of TNF-mediated necrosis. However, a closer
examination of the data raises a conundrum: given the retention
of increased macrophage microbicidal activity in the TNF-high
CYPD morphants, why are their later bacterial burdens not
lowered significantly below those of WT fish (Figure 5A)? Could
an additional pathway of TNF-mediated cell necrosis bemasking
such a hyperresistance phenotype? An analysis of macrophage
loss in the TNF-high CYPDmorphants supported this possibility:
macrophage numbers were not restored in these morphants in
contrast to those in TNF-high RIP1 morphants where ROS over-
production is abolished (Figure 5D).
Acid Sphingomyelinase-Mediated Ceramide Production
Contributes to Cell Necrosis in the TNF-High State
One additional pathway of TNF-mediated necrosis occurs
through activation of sphingomyelinases that results in the
production of ceramide, an inducer of both apoptosis and
RIP1-dependent programmed necrosis (Thon et al., 2005; Van-
denabeele et al., 2010). Lysosomal acid sphingomyelinase
(aSMase) can also be activated by oxidation (Dumitru and
Gulbins, 2006), making it a promising candidate mediator of the
residual cell necrosis in theTNF-high animals.Morpholino knock-
down of aSMase revealed the substantial contribution of this
pathway: aSMase morphants phenocopied CYPD morphants
under high TNF conditions, preserving increased macrophagected with TNF or vehicle. White arrowheads show extracellular bacteria.
1 day postinjection with TNF or vehicle. Difference not significant by Student’s
larva. Scale bar, 10 mm.
exact test).
ae 6 hr after incubation with CM-H2DCFDA. Arrowheads point to infected
WT siblings infectedwithMmormock-infected (see Experimental Procedures)
epresentative of two independent experiments.
indicated time points after injection of TNF or vehicle in presence or absence of
orphant siblings at the indicated time points after injection of TNF or vehicle.
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Figure 3. TNF Excess Mediates Necrosis through the RIP1-RIP3 Kinase Pathway
(A) Zebrafish RIP1 and RIP3 amino acid residue analysis for protein domains. RHIM, RIP homotypic interaction motif; aa, amino acid residue. Numbers indicate
percent identity between zebrafish and human domains.
(B) Mean (±SEM) number of bacteria per infected macrophage in WT and RIP1 morphant siblings on LTA4H-high or WT background. ***p < 0.001 (one way
ANOVA with Tukey’s posttest). Representative of two independent experiments.
(C) FPC in WT and RIP1 morphant siblings on LTA4H-high or WT background. **p < 0.01; ***p < 0.001 (one-way ANOVAwith Tukey’s posttest). Representative of
three independent experiments.
(D) Percentage of animals in (C) with cording among WT, RIP1 morphants, and RIP1 morphants on LTA4H-high background. *p < 0.05; **p < 0.01 (Fisher’s
exact test).
(E) Mean (±SEM) number of bacteria per infected macrophage in WT and RIP3 morphant siblings on LTA4H-high or WT background. ***p < 0.001 (one way
ANOVA with Tukey’s posttest). Representative of two independent experiments.
(F) FPC in WT and RIP3 morphant siblings on LTA4H-high or WT background. ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Representative of three
independent experiments.
(legend continued on next page)
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microbicidal activity while reversing later bacterial burdens to
WT levels but not below (Figures 5E and 5F). That this phenotype
was due to ceramide reduction was shown by reproducing it
with acid ceramidase overexpression (Figures 5E and 5F).
If these two pathways together arewholly responsible for TNF-
mediated necrosis, then knocking them down together should
prevent necrosis completely, allowing the increased microbici-
dal capacity of macrophages to then confer hyperresistance.
Assessment of macrophage survival and bacterial burdens in
single and double knockdowns of the two pathways showed
this to be the case. The residual levels of cell necrosis in the
single knockdowns were completely eliminated in the double
knockdowns (Figure 5G). Accordingly, these animals were now
hyperresistant to infection, with bacterial burdens being reduced
belowWT levels even at later stages of infection (Figure 5H). NAC
treatment reverted the bacterial loads of these animals to WT
levels, confirming their hyperresistance to be due to increased
ROS production (Figure 5I). Together, these experiments sug-
gest that preventing death of ROS-producing macrophages
can prolongmicrobicidal activity and substantially reduce bacte-
rial burdens over WT.
Pharmacological Interventions in the TNF-Mediated
Necrosis Pathway as Host-Targeting Antitubercular
Drugs
There is currently substantial interest in pharmacologic manipu-
lation of programmed necrosis pathways in a variety of inflam-
matory diseases (Galluzzi et al., 2011; Vandenabeele et al.,
2010). In the course of elucidating the high TNF-mediated
pathway, we used small molecules, several of which are
approved drugs (NAC, amifostine), drugs in clinical trials
(TEMPOL), or over the counter supplements (reduced gluta-
thione) (Table S1). These agents all act upstream of ROS produc-
tion, thus reverting intramacrophage bacterial burdens and later
bacterial burdens to WT levels but no lower (e.g., Figures 2A and
2B). With our discovery that genetic interventions downstream of
ROS have the potential to convert TNF-mediated hypersuscep-
tibility to a hyperresistant state, we searched for drugs that could
inhibit these pathways.
We identified two candidates. The first, alisporivir (Debio 025),
is an orally administered drug that impedes CYPD’s ability to
regulatemPTPC and is currently in Phase III clinical development
for Hepatitis C (Quarato et al., 2012; Tiepolo et al., 2009). As with
the CYPD morpholino, alisporivir (10 mM) reversed the suscepti-
bility of LTA4H-high animals toWT levels while retaining the early
improvedmicrobicidal activity (Figures 6A and 6B and Table S1).(G) Percentage of animals in (F) with cording among WT, RIP3 morphants and R
(H)Mean (±SEM) number of bacteria per infectedmacrophage inWT andRIP1 or R
with Tukey’s posttest).
(I) FPC in infected WT and RIP1 or RIP3 morphant larvae injected with TNF or ve
(J) Percentage of animals in (I) with cording among WT, RIP1 and RIP3 morphan
(K) Mean (±SEM) number of bacteria per infected macrophage in WT and LTA4H-
control. ***p < 0.001 (one way ANOVA with Tukey’s posttest). Representative of
(L) FPC in WT and LTA4H-high larvae in presence of 10 mM Necrostatin-1 or 10 m
Tukey’s posttest). Representative of two independent experiments.
(M) Percentage of animals in (L) with cording among WT and LTA4H-high larvae
*p < 0.05 (Fisher’s exact test).
See also Figures S4 and S5.Like the CYPDmorpholino, alisporivir’s failure to confer hyperre-
sistance could be explained by residual macrophage necrosis
(Figure 6C). These results suggested that it was acting spe-
cifically on CYPD, substantiated further by its failure to alter
bacterial burdens either in WT or LTA4H-low animals (Figures
6A and 6D).
Second, we tested the tricyclic class of antidepressants,
known to promote specific proteolytic degradation of aSMase
and thereby expected to reduce cell death through inhibiting cer-
amide production (Elojeimy et al., 2006) (Table S1). As predicted
by our model, desipramine, a tricyclic antidepressant in clinical
use for nearly 50 years, reduced susceptibility specifically of
LTA4H-high but notWT animals (Figure 6E). Toxicity of alisporivir
and desipramine at their effective doses of 10 and 7.5 mM,
respectively, precluded using this dose combination to test for
their predicted synergy. Instead, we asked if subtherapeutic
concentrations of each drug (7.5 mM of alisporivir and 5 mM of
desipramine) would be effective in combination (Takaki et al.,
2012). We found that they were: combination therapy signifi-
cantly reduced bacterial burdens of TNF-high fish and trended
toward making the fish hyperresistant, as predicted (Figure 6F).
As a final demonstration of the specificity of the two drugs, we
tested their effects in aSMase and CYPD morphants. If each
drug is specific to its pathway, then alisporivir but not desipra-
mine should further reduce the bacterial burdens of the aSMase
morphants. Conversely, desipramine, but not alisporivir, should
further reduce the bacterial burdens of the CYPD morphants.
Exactly this was observed, confirming the specificity of action
of the two drugs (Figures 6G and 6H).
DISCUSSION
Using the zebrafish, we have identified a potential mechanism to
account for the worse outcomes in TB meningitis patients with
proinflammatory LTA4H genotypes (Tobin et al., 2012) (Figure 7
and Table S2). This mechanism may account for outcomes in
other forms of TB as well. Our findings explain the previously
observed dichotomy of the LTA4H-high zebrafish phenotypes:
an initial enhancement of macrophage microbicidal activity fol-
lowed by increased bacterial burden. We identify mitochondrial
ROS as critical mediators of both phenotypes: the latter is
accomplished by triggering cell lysis, thus not only terminating
beneficial ROS production but also releasing the bacteria into
the permissive extracellular milieu. ROS-dependent cell necrosis
is mediated by at least two pathways that each participates sub-
stantially in cell death. Blocking either reverts bacterial burdensIP3 morphants on LTA4H-high background. **p < 0.01 (Fisher’s exact test).
IP3morphant larvae injected with TNF or vehicle. ***p < 0.001 (one way ANOVA
hicle. **p < 0.01 (one-way ANOVA with Tukey’s posttest).
ts injected with TNF or vehicle. *p < 0.05; **p < 0.01 (Fisher’s exact test).
high larvae in presence of 10 mMNecrostatin-1 or 10 mMNecrostatin-1 inactive
two independent experiments.
M Necrostatin-1 inactive control. *p < 0.05; ***p < 0.001 (one-way ANOVA with
in presence of 10 mM Necrostatin-1 or 10 mM Necrostatin-1 inactive control.
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Figure 4. The TNF-RIP1-RIP3 Axis Mediates Necrosis of Infected Macrophages through Mitochondrial ROS Production
(A) FPC in WT and LTA4H-high larvae in presence or absence of 10 mM Necrox-5. **p < 0.01 (one-way ANOVA with Tukey’s posttest). Representative of two
independent experiments.
(B) Percentage of animals in (A) with cording among WT and LTA4H-high larvae in presence or absence of 10 mM Necrox-5. *p < 0.05; ***p < 0.001 (Fisher’s
exact test).
(C) FPC in WT and LTA4H-high larvae injected with TNF or vehicle in presence or absence of 10 mM Necrox-5. *p < 0.05 (one-way ANOVA with Tukey’s
posttest).
(D) Percentage of animals in (C) with cording amongWT and LTA4H-high larvae injected with TNF or vehicle in presence or absence of 10 mMNecrox-5. *p < 0.05
(Fisher’s exact test).
(legend continued on next page)
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to WT levels; blocking both converts the hypersusceptible state
to a hyperresistant one.
This understanding leads to potential therapeutic interven-
tions. Several of the ROS scavengers we tested are being used
or tested as drugs. Even more exciting is our identification of
two oral drugs, alisporivir and desipramine, that work both singly
and synergistically to block ROS-mediated cell necrosis (Fig-
ure 7). Interventions in this pathway are beneficial only to the
genotypes with increased ROS production, but do not adversely
affect those where the high TNF pathway is not operant. This is in
contrast to more upstream interventions, e.g., glucocorticoids in
which only one of the two genotypes—LTA4H-high or LTA4H-
low—benefitted while the other was harmed (Tobin et al., 2012).
TNF-mediated RIP1/RIP3-dependent cell necrosis appears to
be a mechanism for control of replication of viral pathogens via
cellular niche destruction (Vandenabeele et al., 2010). Like other
proinflammatory mechanisms, this mechanism is also impli-
cated in the pathology of a growing list of inflammatory diseases,
including sepsis (Duprez et al., 2011; Galluzzi et al., 2011). The
lifestyle of the pathogenic mycobacteria makes them adept at
exploiting this host-mediated necrosis: while using macro-
phages for systemic invasion of the host and dissemination
therein, they later benefit from becoming extracellular so as to in-
crease their numbers and their transmissibility (Clay et al., 2007;
Davis and Ramakrishnan, 2009; Ramakrishnan, 2012). Indeed,
our data suggest that excess TNF is necessary but not sufficient
for macrophage necrosis. Using yet unknown determinants, the
bacterium plays a critical role in TNF-mediated ROS production.
These might not represent classical virulence determinants but
ones that only mediate virulence in the context of certain host in-
flammatory profiles. Mycobacteria are already known to induce
host lipoxin production that can induce a nonprogrammed cell
necrosis by inhibiting TNF production (Cassidy-Stone et al.,
2008; Tobin et al., 2010). This work now implicates mycobacte-
rial factors in programmed necrosis as well. Several other
intracellular pathogens have been shown to induce caspase-1-
dependent phagocyte lysis, but this appears to be host benefi-
cial (Bergsbaken et al., 2009). Recently, Salmonella was also
found to mediate a pathogen-beneficial RIP-1-mediated cell
necrosis (Robinson et al., 2012). Although that study implicated
type 1 interferons, the events such as ROS production and
mPTPC formation that we have uncovered downstream of TNF
may be operant in Salmonella pathogenesis as well.
Our data reveal ROS as both susceptibility and resistance
factors in TB, and its role involves a complex interplay between
host and pathogen. Mycobacteria have evolved to counter ROS
both by inhibiting their production and by detoxifying them (Ehrt
and Schnappinger, 2009). Despite these bacterial mechanisms,(E) FPC inWT and LTA4H-high larvae in presence or absence of 10 mMNecrosulfo
Representative of three independent experiments.
(F) Mean (±SEM) number of bacteria per infected macrophage in WT and PGAM
ANOVA with Tukey’s posttest). Representative of two independent experiments.
(G) FPC in WT and PGAM5 morphant siblings on WT or LTA4H-high background
independent experiments.
(H) Percentage of animals in (G) with cording among WT and PGAM5 morphants
(I–K) Confocal and bright field images of different infected macrophages in 1 dpi
(Also see Figure S6).ROS production appears to have at least a modest effect in re-
strainingmycobacteria, as shown by recent work in the zebrafish
suggesting that neutrophils can kill phagocytosed mycobacteria
through oxidative mechanisms (Yang et al., 2012). This may be
because the higher levels of ROS produced by neutrophils are
not effectively countered by mycobacterial mechanisms. Our
current work indicates that ROS overproduction inmacrophages
is also not countered by mycobacteria; however, it is host detri-
mental rather than host protective. Moreover, our finding that
macrophage ROS production is mitochondrial and dependent
on a bacterial component is intriguing in light of reports that spe-
cific mycobacterial determinants target the host mitochondrion
to produce cell death (Cadieux et al., 2011; Sohn et al., 2011).
Such mycobacterial-mitochondrial interactions may potentiate
ROS overproduction in the context of host-driven pathways.
Our discovery of the role of ceramide in cell necrosis links data
implicating these host lipids in TNF-mediated necrosis to host
lipidomic and proteomic analyses showing that aSMAse activity
is increased during Mtb infection (Lee et al., 2006a; Lee et al.,
2011). Mtb infection in cultured macrophages can lead to lyso-
some-dependent infected cell necrosis by promoting lysosomal
membrane permeabilization, release of lysosomal enzymes, and
lipase activation, which promotes mitochondrial disruption (Lee
et al., 2011). However, this mode of cell death is driven by high
intracellular bacterial load and is mPTPC independent. Although
we cannot tell if ceramide production in our system acts through
the mitochondrion or not, we do know that it occurs in the
context of high TNF infection even when bacterial burdens are
very low. Ceramide production may be triggered by bacterially
induced ROS. Furthermore, precisely how ceramide works to
lyse macrophages is unknown; it could be acting on the mito-
chondrion to potentiate CYPD-mediated mPTPC or elsewhere
in the cell (Thon et al., 2005). Regardless of mechanism, this
pathway may be important in advanced human TB, where cer-
amide is increased in necrotic lung granulomas (Kim et al.,
2010b).
Although our findings suggest the potential for dual blockade
of the CYPD and ceramide-mediated necrosis pathways to pro-
duce hyperresistance, they must be interpreted with caution.
Increased ROS production is likely to eventually kill the cell
even with both of these pathways blocked—through lipid perox-
idation, DNA damage, activation of proapoptotic factors, and
ATP depletion (Vandenabeele et al., 2010). Hence the delay in
cell death by blocking these two pathways would be most useful
if it is long enough to allow macrophage ROS to eradicate the
bacteria. Macrophage sterilization may be potentiated by com-
bining necrosis-blocking drugs with traditional antitubercular
drugs.namide (NSA). **p < 0.01; ***p < 0.001 (one-way ANOVAwith Tukey’s posttest).
5 morphant siblings on WT or LTA4H-high background. ***p < 0.001 (one way
. ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Representative of two
on WT or LTA4H-high background. **p < 0.01 (Fisher’s exact test).
larvae 3 (I), 5 (J), or 6 (K) hr post-TNF injection. Scale bars, 1 mm.
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Figure 5. Cyclophilin D and Ceramide Mediate Cell Necrosis
(A) FPC in WT or CYPDmorphant siblings on WT or LTA4H-high background. **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Representative of
three independent experiments.
(B) Mean (±SEM) number of bacteria per infected macrophage in WT, LTA4H-high and CYPD morphant siblings on LTA4H-high background. ***p < 0.001 (one
way ANOVA with Tukey’s posttest). Representative of two independent experiments.
(C) Quantification of ROS production as RFU (±SEM) in infected WT, RIP1, RIP3, PGAM5, and CYPD morphant siblings at indicated time points after TNF or
vehicle injection. (two-way ANOVA).
(D) Number of yellow fluorescent macrophages in 2 dpi Tg(mpeg1:YFP) RIP1 or CYPDmorphant siblings 1 day postinjection with TNF or vehicle. **p < 0.01; ***p <
0.001 (one-way ANOVA with Tukey’s posttest). Representative of two independent experiments.
(E) Mean (±SEM) number of bacteria per infectedmacrophage inWT, LTA4H-high and aSMasemorphants and acid ceramidase-overexpressing (acer) siblings on
WT or LTA4H-high background. ***p < 0.001 (one way ANOVA with Tukey’s posttest). Representative of two independent experiments.
(F) FPC in WT, LTA4H-high, aSMase morphants and acid ceramidase-overexpressing siblings on WT or LTA4H-high background.*p < 0.05; **p < 0.01; ***p <
0.001 (one-way ANOVA with Tukey’s posttest). Representative of two independent experiments.
(G) Number of yellow fluorescent macrophages in 2 dpi Tg(mpeg1:YFP) CYPD morphants and ceramidase-overexpressing siblings 1 day postinjection with TNF
or vehicle. **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Dashed line, control group mean.
(H) FPC in WT, LTA4H-high, CYPD morphants, double CYPD/aSMase morphants, and CYPD morphants-overexpressing simultaneously acid ceramidase on
LTA4H-high background.*p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Representative of two independent experiments. Dashed
line, control group mean.
(I) FPC in WT, LTA4H-high, CYPD morphants and CYPD morphants overexpressing simultaneously acid ceramidase on LTA4H-high background in presence or
absence of 40 mMNAC.*p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s posttest). Representative of two independent experiments. Dashed line,
control group mean.
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Figure 6. Drugs Blocking Cyclophilin D- and
Ceramide-Mediated Necrosis Synergize
as Host-Targeting Therapies for High-TNF
Mediated TB
(A) FPC in WT and LTA4H-high larvae treated with
alisporivir or left untreated. *p < 0.05; **p < 0.01
(one-way ANOVA with Tukey’s posttest). Repre-
sentative of three independent experiments.
(B) Mean (±SEM) number of bacteria per infected
macrophage in WT and LTA4H-high siblings in
presence or absence of alisporivir. ***p < 0.001
(one way ANOVA with Tukey’s posttest). Repre-
sentative of two independent experiments.
(C) FPC in WT siblings injected or not with TNF in
presence or absence of alisporivir. **p < 0.01;
***p < 0.001 (one-way ANOVA with Tukey’s
posttest).
(D) FPC in WT and LTA4H-low siblings in presence
or absence of alisporivir. *p < 0.05 (one-way
ANOVA with Tukey’s posttest).
(E) FPC in WT and LTA4H-high larvae in presence
or absence of desipramine. *p < 0.05; ***p < 0.001
(one-way ANOVA with Tukey’s posttest). Repre-
sentative of three independent experiments.
(F) FPC in WT and LTA4H-high larvae in presence
or absence of desipramine, alisporivir or the
combination of both. *p < 0.05; **p < 0.01; ***p <
0.001 (one-way ANOVA with Tukey’s posttest).
Representative of two independent experiments.
Dashed line, control group mean.
(G) FPC in WT, LTA4H-high and LTA4H-high/
CYPD morphant larvae treated with alisporivir,
desipramine, or left untreated. ***p < 0.001 (one-
way ANOVA with Dunnett’s posttest). Represen-
tative of two independent experiments. Dashed
line, control group mean.
(H) FPC in WT, LTA4H-high and LTA4H-high/
aSMase morphant larvae treated with alisporivir,
desipramine, or left untreated. *p < 0.05; **p < 0.01
(one-way ANOVA with Dunnett’s posttest).
Dashed line, control group mean.Furthermore, we have not directly shown high TNF to be the
culprit in human high-LTA4H-mediated TB susceptibility, only
increased inflammation that may involve different mediators.
Our zebrafish findings, however, have been previously validated
in humans. It is additionally reassuring that the disease-promot-
ing pathway we described is amenable to rationally designed
interventions using chemicals and drugs identified in human sys-
tems (Figure 7). Our finding that necrosulfonamide is effective
makes a particularly strong case for the zebrafish; this chemical,
discovered using a human cell line, was found to be ineffective in
a murine system because it prevents MLKL-RIP3 interaction by
steric hindrance through binding to a nonessential cysteine
residue that is present in humans but not mice (Wang et al.,
2012). Although a clear zebrafish homolog is yet to be annotated,
we have identified a homologous domain corresponding to 42Cell 153, 521–5amino acid residues of the human protein
within the functional sequence (protein
kinase domain), in which the cysteine
residue is conserved (Chromosome 12,nucleotide sequence from 15174549 to 15174674, identities =
16/47 [34%], positives = 27/47 [57%]). Finally, two clinical
studies point to the potential importance of this pathway in
humans. First, the high-expressing LTA4H allele is relatively
rare in Africa (Stranger et al., 2007 and our unpublished data),
yet glucocorticoids have been shown to have similar, small
beneficial effects in TB meningitis in African and Vietnamese
populations (Schoeman et al., 1997; Thwaites et al., 2004), sug-
gesting that a hyperinflammatory state in TB may arise via alter-
native mechanisms, perhaps through genetic variation in other
components of the pathway detailed in this investigation.
Second, that these susceptibility pathways could be TNF-medi-
ated is supported by a clinical trial from Uganda showing that
pulmonary TB patients had increased clearance of sputum bac-
teria when treated with TNF blocking agents (Wallis, 2005).34, April 25, 2013 ª2013 Elsevier Inc. 531
Figure 7. TNF-Dependent Programmed
Necrosis Pathways Showing Genetic and
Chemical Interventions Used in This Study
Dcm, dissipation of mitochondrial membrane
potential. See also Table S3.In summary, variants inmultiple human loci involving our newly
discovered pathway may alter host response to mycobacterial
infection. Given the druggability of this pathway, their iden-
tification in human prospective studies is promising. Finally,
TNF-mediated ROS production may play a similar role in the
pathogenesis of other diseases where TNF is known to play
a pathogenic role, such as rheumatoid arthritis, ankylosing
spondylitis, sarcoidosis, Crohn’s disease and granulomatosis
with polyangiitis (Keystone and Ware, 2010) in which ROS
scavengers, alisporivir and the tricyclic antidepressants may
be effective.
EXPERIMENTAL PROCEDURES
Bacterial Strains
WT Mm (strain M - ATCC #BAA-535) or the Mm erp mutant constitutively
expressing tdTomato (red fluorescence) and Mm expressing tdKatushka2
(far-red fluorescence) or EBFP2 (blue fluorescence) were used for fluores-
cence microscopy and quantitation of intracellular bacterial burdens (Tobin
et al., 2012). erp mutant Mm was used to enumerate intracellular bacteria
and WT Mm was used for all other assays as detailed in Extended Experi-
mental Procedures.
Zebrafish Infection
Zebrafish experiments were conducted in conformity with the Public Health
Service Policy on Humane Care and Use of Laboratory Animals using proto-
cols approved by the Institutional Animal Care and Use Committee of the
University of Washington. A total of 90–150 Mm was injected into the caudal532 Cell 153, 521–534, April 25, 2013 ª2013 Elsevier Inc.vein of 36-48 hpf larvae of the AB line and the Tg(mpeg1:YFP) line created
from it as detailed in Extended Experimental Procedures.
Morpholinos
Morpholinos described in Table S3 were injected at the 1–4 cell stage as
described previously (Tobin et al., 2012).
ROS Detection and Quantification Assay
ROS accumulation was assessed by the levels of the oxidized form of the cell-
permeant ROS indicator acetyl ester of 5-(and 6-) chloromethyl-20,7’-dichlor-
odihydrofluorescein diacetate (CM-H2DCFDA) (Invitrogen), as detailed in
Extended Experimental Procedures.
Mitochondrial ROS and Cell Death Detection Assays
Mitochondrial ROS production and cell death was assayed by the levels of the
oxidized form of the cell-permeant mitochondrion-targeted ROS indicator,
MitoTracker Red CM-H2Xros and the live cell impermeant nucleic acid stain
SYTOX Green (both from Invitrogen) as detailed in Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.03.022.
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